How much is the eczema market worth, and how is it expected to expand?
The eczema market size has grown strongly in recent years. It will grow from $16.41 billion in 2024 to $17.81 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing prevalence of autoimmune diseases, rising eczema cases, increasing approvals from authorities, rising incidences of air pollutants, and increasing burden of allergic reactions.
The eczema market size is expected to see strong growth in the next few years. It will grow to $24.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing demand for treatment atopic dermatitis, increasing operational activities, increasing awareness of eczema, increasing incorporation of biologics, increasing adoption of telemedicine platform. Major trends in the forecast period include strategic collaboration, emerging therapies, injectable drugs, and personalized medicine.
Get Your Free Sample of The Global Eczema Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21179&type=smp
Which industry factors have accelerated the eczema market’s expansion?
The increasing prevalence of autoimmune disorders is expected to propel the growth of the eczema market going forward. Autoimmune disorders refer to conditions in which the body’s immune system mistakenly attacks its healthy cells, tissues, or organs, leading to inflammation and damage. The increasing prevalence of autoimmune disorders is attributed to genetic susceptibility, environmental factors, infections, dietary changes, and lifestyle factors such as stress and exposure to pollutants. Autoimmune diseases, such as psoriasis, lupus, and rheumatoid arthritis, are linked to dysregulated immune responses, making individuals more susceptible to eczema and other inflammatory skin conditions. For instance, in November 2024, according to the Versorgungsatlas.de, a Germany-based organization, in 2022, out of 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, leading to a raw prevalence rate of 8.61%. Therefore, the increasing prevalence of autoimmune disorders is driving the growth of the eczema market.
What are the primary segments of the eczema market?
The eczema market covered in this report is segmented –
1) By Type: Atopic Dermatitis, Contact Dermatitis, Seborrheic Dermatitis, Other Types
2) By Treatment Type: Topical Treatments, Oral Medications, Biologics, Phototherapy
3) By Age Group: Children, Adults, Elderly
4) By End User: Hospitals Or Clinics, Dermatology Centers, Home Care, Pharmacies
Subsegments:
1) By Atopic Dermatitis: Topical Steroids, Topical Calcineurin Inhibitors, Moisturizers, Biologic Therapies
2) By Contact Dermatitis: Topical Steroids, Antihistamines, Topical Immunosuppressants, Wet Compresses
3) By Seborrheic Dermatitis: Antifungal Creams or Shampoos, Topical Steroids, Medicated Shampoos, Topical Calcineurin Inhibitors
4) By Other Types: Allergic Dermatitis, Nummular Dermatitis, Neurodermatitis, Dyshidrotic Eczema
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/eczema-global-market-report
Which firms are leading the eczema market?
Major companies operating in the eczema market are Pfizer Inc., AbbieVie Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Amgen, Hoffmann-La Roche AG, Eli Lilly and Co., Siemens Healthineers AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc, Bausch Health Companies Inc., Galderma, Cadila Pharmaceuticals Ltd., LEO Pharma A/S, Almirall, Kyowa Kirin, Alliance Pharma Plc, Encore Dermatology Inc., Arcutis Inc
Which market trends are set to define the future of the eczema market?
Major companies operating in the eczema market are focusing on the development of innovative products, such as eczema care creams, to enhance treatment effectiveness and meet consumer demand for advanced skincare solutions. Eczema care cream is a specialized skincare product designed to soothe, hydrate, and protect the skin affected by eczema, helping to reduce itching, inflammation, and dryness. For instance, in September 2024, Dove, a UK-based personal care brand, launched a new Eczema Care range for babies, which includes the Baby Dove Eczema Care Soothing Bath Treatment and the Baby Dove Eczema Care Cream. The Baby Dove Eczema Care range offers several unique features tailored for infants with eczema. Firstly, the products are formulated with 100% skin-natural nutrients, ensuring they are gentle on sensitive skin. They contain colloidal oatmeal (1.0%), a key ingredient for soothing irritation and maintaining moisture.
Which geographic trends are shaping the eczema market, and which region has the highest market share?
North America was the largest region in the eczema market in 2024. The regions covered in the eczema market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Eczema Market Report 2025 Offer?
The eczema market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Eczema is a chronic inflammatory skin condition characterized by redness, itching, dryness, and irritation. It occurs due to genetic and environmental factors, leading to a compromised skin barrier and an overactive immune response. Eczema can affect people of all ages but is more common in children. The condition may present in flare-ups triggered by allergens, irritants, stress, or climate changes.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21179
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
